About
NeuroAudit, the developer of neuro stimulus neurotechnology, is currently working on a cognitive boost patch for the treatment of brain disorders such as Alzheimers disease and cognitive disorders. Based on blood conduction directly to the brain using a unique algorithm, the device transmits a noninvasive, pure signal through a patch attached to the skin. The device is not mounted in or near the ears of the patient. NeuroAudit is focused on addressing the complexities of neurological disorders by continuously monitoring the state of the brain while analyzing the measured data and controlling brain stimulation in real time in order to better understand the impact on the brain. The companys noninvasive stimulation has showed improvements in certain cognitive operations and was able to send a pure tone to a completely deaf individual via the blood using an ultrasonic algorithm. Additional use cases include creating a new brain-hearing sense to expand the range of the human brains hearing up to 100 KHz and using specific modulations to expand a individuals level of cognition.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is NeuroAudit's primary focus in neurotechnology?
- NeuroAudit is developing neuro stimulus neurotechnology, specifically a cognitive boost patch for treating brain disorders like Alzheimer's disease and other cognitive disorders.
- How does NeuroAudit's device transmit signals to the brain?
- NeuroAudit's device transmits a noninvasive, pure signal directly to the brain via blood conduction using a unique algorithm, delivered through a patch attached to the skin.
- What are the key capabilities of NeuroAudit's noninvasive stimulation technology?
- NeuroAudit's noninvasive stimulation has shown improvements in certain cognitive operations and has enabled a completely deaf individual to perceive a pure tone via blood using an ultrasonic algorithm.
- What additional use cases is NeuroAudit exploring for its technology?
- NeuroAudit is exploring use cases such as creating a new brain-hearing sense to expand the human brain's hearing range up to 100 KHz and using specific modulations to expand an individual's level of cognition.
- When was NeuroAudit founded and where is it headquartered?
- NeuroAudit was founded in February 2016 and is headquartered in Gan Sorek, Israel.
- What is NeuroAudit's current funding stage and total capital raised?
- NeuroAudit is currently in the Seed stage and has raised a total of $200,000 USD. For a full financing history, please refer to startupim.
- How many employees does NeuroAudit currently have?
- NeuroAudit currently has between 1 and 10 employees.
- What recognition did NeuroAudit receive in 2022?
- In April 2022, NeuroAudit received the Biotechnology Award 2022 as the "Most Innovative Neurotechnology Company in the Middle East."
- Who is a key founder of NeuroAudit?
- Dan Anzyo is a founder of NeuroAudit.